Target intelligence / Profile preview

Gamma-aminobutyric acid type A receptor alpha-6 beta-2 gamma-2 subtype (GABA-A receptor α6β2γ2)

Target
GABA-A receptor α6β2γ2
Molecular classification
Ion channel [1, 8], Ligand-gated ion channel [1, 8], Cys-loop receptor family [8, 15], GABA-A receptor [1, 3]
01

Overview

The GABA-A receptor α6β2γ2 subtype is a heteropentameric ligand-gated ion channel that mediates inhibitory neurotransmission in the central nervous system [1, 8]. It is primarily expressed in the granule cells of the cerebellum, where it plays a specialized role in regulating motor coordination and sensory input [2, 15]. Unlike many other GABA-A receptor subtypes, the α6-containing variant is "diazepam-insensitive" due to a specific arginine residue in the α6 subunit that prevents the binding of classical benzodiazepines [4, 15]. This receptor subtype contributes significantly to tonic inhibition, providing a continuous inhibitory tone that modulates neuronal excitability [1, 12]. Dysregulation of α6β2γ2 receptors has been linked to conditions such as tinnitus, essential tremor, and neuropsychiatric disorders like schizophrenia [1, 9]. Pharmacological targeting of this subtype with selective modulators like hispidulin or DK-I-56-1 is being explored for therapeutic potential in treating cerebellar-related motor deficits and sensory hypersensitivity [1, 2].

Other names
GABRA6-GABRB2-GABRG2 receptorα6β2γ2 GABA-A receptorDiazepam-insensitive GABA-A receptor (α6-containing)
02

Mechanism of action

Positive allosteric modulation, Negative allosteric modulation, Agonism [1, 2, 4]

03

Biological functions

Inhibitory neurotransmission [1, 8]Chloride ion transport [1, 3]Tonic inhibition [1, 12]Regulation of cerebellar excitability [2, 15]
04

Disease associations

Tinnitus [1]Essential tremor [1]Migraine [1]Schizophrenia [1, 9]Epilepsy [1, 10]Alcoholism [1, 21]
05

Safety considerations

Ataxia [1, 21]Sedation [1, 12]Motor impairment [21]Tolerance [9]
06

Interacting drugs

Hispidulin [1]

4 more in the full profile.

07

Biomarkers

GABRA6 gene expression [1, 21]PET imaging with [11C]Ro15-4513 [20]

Beyond the preview

Go deeper on Gamma-aminobutyric acid type A receptor alpha-6 beta-2 gamma-2 subtype (GABA-A receptor α6β2γ2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-6 beta-2 gamma-2 subtype (GABA-A receptor α6β2γ2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call